|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 216.12 USD | +3.04% |
|
+0.04% | +22.80% |
| 02/07 | Biogen Says Research, Milestone Charges to Reduce Earnings in Q2, Q3 | MT |
| 01/07 | HEALTH ROUNDS-Old cancer drug may help restore fertility for certain women | RE |
| Market Cap | 3.19TCr 2.79TCr 2.56TCr 2.39TCr 4.53TCr 3,03800Cr 4.6TCr 31TCr 12TCr 1,49300Cr 12TCr 12TCr 5,14600Cr | P/E 2026 * |
34.9x | P/E 2027 * | 18.1x |
|---|---|---|---|---|---|
| Enterprise Value | 3.73TCr 3.26TCr 2.99TCr 2.79TCr 5.3TCr 3,55000Cr 5.38TCr 36TCr 14TCr 1,74500Cr 14TCr 14TCr 6,01200Cr | EV / Sales 2026 * |
3.71x | EV / Sales 2027 * | 3.4x |
| Free-Float |
85.96% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Biogen Inc.
| 1 day | +3.04% | ||
| 1 week | +0.04% | ||
| Current month | +0.03% | ||
| 1 month | +10.29% | ||
| 3 months | +21.87% | ||
| 6 months | +21.54% | ||
| Current year | +22.80% |
| 1 week | 209.67 |  | 219.72 |
| 1 month | 192.18 | | 219.72 |
| Current year | 160.36 | | 219.72 |
| 1 year | 121.05 | | 219.72 |
| 3 years | 110.04 | | 287.6 |
| 5 years | 110.04 | | 372.12 |
| 10 years | 110.04 | | 468.55 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 66 | 14/11/2022 | |
Robin Kramer
DFI | Director of Finance/CFO | 60 | 01/03/2025 |
Guy Hadari
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Eric Rowinsky
BRD | Director/Board Member | 69 | 23/03/2010 |
Stephen Sherwin
BRD | Director/Board Member | 77 | 01/01/2010 |
William Hawkins
BRD | Director/Board Member | 72 | 19/06/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 09/06 | Free | Director | 1,505 | 0.0010% | ||
| 09/06 | Free | Chairman | 2,005 | 0.0014% | ||
| 09/06 | Fiscal year | Director | 6,245 | 0.0042% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.04% | +0.04% | +62.66% | -24.29% | 3.19TCr | |
| +4.73% | +3.38% | +19.53% | -8.89% | 6.66TCr | |
| -1.93% | +0.39% | +58.62% | +226.33% | 5.65TCr | |
| +1.07% | +42.10% | +42.10% | +42.10% | 4.3TCr | |
| +3.45% | +6.04% | -49.46% | -55.91% | 4.05TCr | |
| +10.01% | +18.57% | +161.59% | -34.48% | 3.16TCr | |
| +2.68% | +2.73% | +70.72% | +88.24% | 2.33TCr | |
| +2.87% | +16.83% | +3.78% | +192.67% | 1.95TCr | |
| -0.13% | +2.75% | +67.48% | +130.07% | 1.72TCr | |
| +3.58% | +9.89% | +75.47% | +344.90% | 1.51TCr | |
| Average | +2.94% | +8.96% | +51.25% | +90.08% | 3.45TCr | |
| Weighted average by Cap. | +2.83% | +7.46% | +45.08% | +67.03% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.01TCr 878.79Cr 807.61Cr 752.79Cr 1.43TCr 96TCr 1.45TCr 9.7TCr 3.77TCr 47TCr 3.77TCr 3.69TCr 1,62100Cr | 1.04TCr 907.54Cr 834.03Cr 777.41Cr 1.47TCr 99TCr 1.5TCr 10TCr 3.89TCr 49TCr 3.9TCr 3.81TCr 1,67400Cr |
| Net income | 152.22Cr 133.07Cr 122.29Cr 113.99Cr 216.21Cr 14TCr 219.49Cr 1.47TCr 570.74Cr 7.12TCr 571.38Cr 559.11Cr 25TCr | 196.89Cr 172.12Cr 158.18Cr 147.44Cr 279.65Cr 19TCr 283.89Cr 1.9TCr 738.21Cr 9.21TCr 739.04Cr 723.17Cr 32TCr |
| Net Debt | 537.21Cr 469.63Cr 431.59Cr 402.29Cr 763.03Cr 51TCr 774.6Cr 5.18TCr 2.01TCr 25TCr 2.02TCr 1.97TCr 87TCr | 334.98Cr 292.84Cr 269.12Cr 250.85Cr 475.8Cr 32TCr 483.01Cr 3.23TCr 1.26TCr 16TCr 1.26TCr 1.23TCr 54TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/26/02 | $216.12 | +3.04% | 11,55,165 |
| 01/26/01 | $209.74 | -2.93% | 11,38,639 |
| 30/26/30 | $216.06 | -0.26% | 10,91,325 |
| 29/26/29 | $216.63 | +0.28% | 12,79,990 |
| 26/26/26 | $216.03 | +6.97% | 23,74,525 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BIIB Stock
Select your edition
All financial news and data tailored to specific country editions
